Realigning United States Core Childhood Vaccine Recommendations With Best Practices From Peer, Developed Countries

Executive orderSigned 05/29Federal Register 06/03Executive Order 14407Open the original

Summary

President Trump orders the core childhood vaccine schedule aligned with peer developed countries, citing an HHS assessment that the United States recommends more childhood vaccines than any peer nation, and directs the CDC and ACIP to review the assessment and latest clinical data.

By industry

Healthcare & Drug Pricing1 trading day−1.0%p15 stocks5 trading days+0.5%p15 stocks20 trading days+8.9%p15 stocks
“the core childhood vaccine schedule should be aligned with scientific evidence and best practices from peer, developed countries”

Day by day after the announcement

Healthcare & Drug Pricing stocks and the S&P 500 after the announcement, cumulative %
Day	Healthcare & Drug Pricing stocks	S&P 500
26/05/28	0.0%	0.0%
26/05/29	−0.9%	+0.1%
26/06/01	−2.4%	+0.2%
26/06/02	−3.0%	+0.6%
26/06/03	−2.5%	−0.6%
26/06/04	+0.5%	+0.1%
26/06/05	+1.9%	−2.6%
26/06/08	+1.4%	−2.2%
26/06/09	+2.5%	−2.5%
26/06/10	+1.9%	−4.1%
26/06/11	+3.1%	−2.1%
26/06/12	+3.4%	−1.7%
26/06/15	+2.4%	−0.2%
26/06/16	+2.4%	−0.6%
26/06/17	+1.3%	−1.6%
26/06/18	−0.5%	−1.0%
26/06/22	+0.7%	−1.5%
26/06/23	+2.2%	−2.8%
26/06/24	+2.2%	−2.4%
26/06/25	+3.4%	−2.8%
26/06/26	+5.7%	−3.2%

Korean stocks in these industries

Samsung Biologics 207940
Celltrion 068270
SK Biopharmaceuticals 326030

Trades in these industries around the announcement

Members' and insiders' trades in the industries' stocks, 30 days before to 30 days after.

Dermot Mark DurcanDirector
BuyCencora
Buy
Cencora
COR
$1.1M
4,000 sh
$1.1M
Filed 06/22
Traded 06/18
Dermot Mark DurcanDirector
BuyCencora
Buy
Cencora
COR
$1.1M
4,000 sh
$1.1M
Filed 05/28
Traded 05/28
Lauren M. TylerDirector
BuyCencora
Buy
Cencora
COR
$148.6K
550 sh
$148.6K
Filed 06/24
Traded 06/22
Lilly EndowmentOther
SellELI Lilly
Sell
ELI Lilly
LLY
$13.6M
13,620 sh
$13.6M
Filed 05/07
Traded 05/06
Larry RobbinsDirector
SellCVS Health
Sell
CVS Health
CVS
$187.3M
1,983,387 sh
$187.3M
Filed 05/21
Traded 05/19
Larry RobbinsDirector
SellCVS Health
Sell
CVS Health
CVS
$74.6M
797,628 sh
$74.6M
Filed 05/21
Traded 05/20
Larry RobbinsDirector
SellCVS Health
Sell
CVS Health
CVS
$34.6M
370,462 sh
$34.6M
Filed 05/21
Traded 05/21
John BoozmanSenator · Republican · AR
BuyUnitedhealth Group
Buy
Unitedhealth Group
UNH
$1K–$15K
Joint
$1K–$15K
Reported 07/13
Traded 06/04
Kathryn E. WengelEVP, Chief TO and Risk Officer
SellJohnson & Johnson
Sell
Johnson & Johnson
JNJ
$2.4M
10,000 sh
$2.4M
Filed 06/12
Traded 06/11
Lilly EndowmentOther
SellELI Lilly
Sell
ELI Lilly
LLY
$2.2M
2,208 sh
$2.2M
Filed 05/07
Traded 05/06
Larry RobbinsDirector
SellCVS Health
Sell
CVS Health
CVS
$14.5M
152,691 sh
$14.5M
Filed 05/21
Traded 05/20
Daniel Patrick O'DayChairman & CEO
Sell10b5-1 planGilead Sciences
Sell10b5-1 plan
Gilead Sciences
GILD
$1.4M
10,900 sh
$1.4M
Filed 06/02
Traded 06/01
David CordaniChairman & CEO
Sell10b5-1 planCigna Group
Sell10b5-1 plan
Cigna Group
CI
$11.9M
41,099 sh
$11.9M
Filed 05/14
Traded 05/12
David CordaniChairman & CEO
Sell10b5-1 planCigna Group
Sell10b5-1 plan
Cigna Group
CI
$11.4M
38,487 sh
$11.4M
Filed 05/14
Traded 05/12
Tommy TubervilleSenator · Republican · AL
Full salePfizer
Full sale
Pfizer
PFE
$15K–$50K
Joint
$15K–$50K
Reported 07/16
Traded 06/08
David CordaniChairman & CEO
Sell10b5-1 planCigna Group
Sell10b5-1 plan
Cigna Group
CI
$10.3M
34,641 sh
$10.3M
Filed 05/14
Traded 05/12
Brian S. TylerCEO
Sell10b5-1 planMcKesson
Sell10b5-1 plan
McKesson
MCK
$6.6M
8,463 sh
$6.6M
Filed 06/18
Traded 06/17
Larry RobbinsDirector
SellCVS Health
Sell
CVS Health
CVS
$6.4M
66,881 sh
$6.4M
Filed 05/21
Traded 05/20
Tilak MandadiEVP, Chief Exp & Tech Officer
SellCVS Health
Sell
CVS Health
CVS
$6.2M
69,551 sh
$6.2M
Filed 05/11
Traded 05/08
David CordaniChairman & CEO
Sell10b5-1 planCigna Group
Sell10b5-1 plan
Cigna Group
CI
$4.6M
15,319 sh
$4.6M
Filed 05/14
Traded 05/12